Purchase Order 75N92026P00049
- Not listed
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $53,205.12 to Becton, Dickinson and Company (BD Biosciences) on January 1, 2026, for maintenance coverage of its LSRFortessa flow cytometry system and throughput sampler. This firm fixed-price contract, which serves as a child delivery order under a larger indefinite delivery vehicle, will be performed in San Jose, California and is scheduled for completion by December 31, 2026. The award was made without...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a Delivery Order contract to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for maintenance and service support of an LSRFortessa flow cytometry instrument. Valued at $52,736.04 with a firm fixed-price structure, this contract will support the NHLBI's Flow Cytometry Core facility, a state-of-the-art resource dedicated to enabling biomedical research conducted by NHLBI investigators. The...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order to Becton, Dickinson and Company (BD), through its BD Biosciences division, for maintenance services on the NHLBI Directorate's Flow Cytometry Core FACSymphony A5 instrument. This $48,097.92 firm fixed-price contract, with no set-aside designation, runs through December 31, 2026, and represents a continuation of maintenance support for critical research instrumentation. As a child contract under BD's larger federal...
- This is a $51,828.84 firm-fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance of Fortessa flow cytometer analyzers. The contract has a period of performance through January 12, 2026. BD is a global medical technology company that provides a range of biomedical research and clinical instruments, including flow cytometers, as well as...
- The National Heart, Lung, and Blood Institute (NHLBI), part of the Department of Health and Human Services, awarded a $42,476.04 firm fixed-price purchase order contract to Becton, Dickinson and Company for maintenance of a BD Fortessa Flow Cytometer Analyzer. The contract provides comprehensive service including unlimited phone support, emergency repairs, parts and labor coverage, and preventative maintenance. Becton, Dickinson is the sole source provider as the manufacturer of the...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $22,107.60 firm fixed-price purchase order to Becton, Dickinson and Company's BD Biosciences division for instrument service contract support to the Flow Cytometry Core facility. The single award contract, effective February 1, 2026 through January 31, 2027, provides maintenance and technical support services essential to sustaining the state-of-the-art flow cytometry facility that supports biomedical research conducted by NHLBI...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...
- Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...
- This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...
- This is a firm fixed-price service contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the maintenance of a Fortessa X-20 flow cytometry instrument. The contract period is from August 18, 2017, to August 17, 2018, with a ceiling value of $24,047.88. BD, a global medical technology company, is the prime contractor for this contract, which does not have a small business...
The National Heart Lung and Blood Institute (NHLBI) awarded a maintenance contract to Becton, Dickinson and Company's BD Biosciences division for the BD Fortessa Flow Cytometer Analyzer on February 1, 2026. This firm fixed-price purchase order, valued at $42,476.04 with completion scheduled for January 31, 2027, supports the NHLBI's biomedical research infrastructure. The contract covers maintenance services for the BD Fortessa, a sophisticated flow cytometry instrument used in cellular and molecular analysis critical to cardiovascular and pulmonary research programs. The work will be performed in Milpitas, California, where BD Biosciences maintains service operations. This award was made without a small business set-aside, reflecting BD's established position as a qualified contractor for specialized laboratory instrumentation support. BD Biosciences, a division of the parent corporation Becton, Dickinson and Company, is a primary federal supplier of flow cytometry systems and associated maintenance services across multiple National Institutes of Health components, including the NHLBI. The company maintains multiple indefinite delivery vehicles and blanket purchase agreements with federal agencies valued in aggregate at several million dollars, including a $1.25 million NIH Clinical Center contract through 2026 with optional extensions. This maintenance award represents routine task order activity under BD's broader framework of providing preventive maintenance, corrective repairs, technical support, and emergency on-site services essential to the continuity of the NHLBI's advanced laboratory operations supporting cardiovascular, pulmonary, and blood disease research.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Maintenance Contract for the BD Fortessa Flow Cyto | 75N92026Q00022 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Award Notice 1/1 | 1/26/26, 3:00 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.5k | 1/26/26 |